These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy. Mata KM, Li W, Reslan OM, Siddiqui WT, Opsasnick LA, Khalil RA. Am J Physiol Heart Circ Physiol; 2015 Nov 15; 309(10):H1679-96. PubMed ID: 26408543 [Abstract] [Full Text] [Related]
5. Sex differences in the participation of endothelial mediators and signaling pathways involved in the vasodilator effect of a selective GPER agonist in resistance arteries of gonadectomized Wistar rats. Peixoto P, Vieira-Alves I, Couto GK, Lemos VS, Rossoni LV, Bissoli NS, Santos RLD. Life Sci; 2022 Nov 01; 308():120917. PubMed ID: 36044974 [Abstract] [Full Text] [Related]
6. GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction. Li Z, Cheng L, Liang H, Duan W, Hu J, Zhi W, Yang J, Liu Z, Zhao M, Liu J. Eur J Cell Biol; 2016 Feb 01; 95(2):100-13. PubMed ID: 26785611 [Abstract] [Full Text] [Related]
7. Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women. Arefin S, Simoncini T, Wieland R, Hammarqvist F, Spina S, Goglia L, Kublickiene K. Maturitas; 2014 Jun 01; 78(2):123-30. PubMed ID: 24796498 [Abstract] [Full Text] [Related]
8. Additive effects of low concentrations of estradiol-17β and progesterone on nitric oxide production by human vascular endothelial cells through shared signaling pathways. Pang Y, Thomas P. J Steroid Biochem Mol Biol; 2017 Jan 01; 165(Pt B):258-267. PubMed ID: 27369115 [Abstract] [Full Text] [Related]